Results 191 to 200 of about 199,379 (359)

The Development and Challenges of PET/MRI Dual‐Modality Imaging Probes—An Update

open access: yesJournal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT The integration of Positron emission tomography (PET) with Magnetic resonance imaging (MRI) combines the functional imaging capabilities of PET with the high‐resolution anatomical detail of MRI, creating a synergistic platform for advanced diagnostic imaging and image‐guided therapies. Central to the success of this dual‐modality system is the
Maryam Sabbaghan   +5 more
wiley   +1 more source

Dietary inclusion of raw potato or high‐amylose‐corn resistant starches fed for different durations: impact on phenotypic responses and indicators of gut health of broiler chickens

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract BACKGROUND This 21‐day study evaluated the effects of feeding durations of graded levels (RSL) of raw potato starch (RPS) or high amylose corn starch (HCS) on growth performance, energy utilization and intestinal biochemical metrics in broiler chickens.
Iyabo W. Oluseyifunmi   +1 more
wiley   +1 more source

STUDIES ON THE RELATION BETWEEN VITAMIN M, XANTHOPTERIN, AND FOLIC ACID

open access: hybrid, 1944
John R. Totter   +4 more
openalex   +1 more source

Engineering Folic Acid‐Modified Nanoparticles to Enhance Letrozole's Anticancer Action

open access: yesMacromolecular Bioscience, EarlyView.
Folate‐functionalized, pH‐sensitive nanoparticles (NPs) are developed for the targeted delivery of letrozole (LTZ) in breast cancer therapy. LTZ‐loaded PCL‐co‐PEG NPs exhibit controlled release, enhanced cytotoxicity, and apoptosis induction in MCF‐7 cells.
Neda Rostami   +7 more
wiley   +1 more source

Mutations in MYO9B are associated with Charcot–Marie–Tooth disease type 2 neuropathies and isolated optic atrophy

open access: yesEuropean Journal of Neurology, Volume 30, Issue 2, Page 511-526, February 2023., 2023
Abstract Background and purpose Charcot–Marie–Tooth disease (CMT) is a heterogeneous group of disorders caused by mutations in at least 100 genes. However, approximately 60% of cases with axonal neuropathies (CMT2) still remain without a genetic diagnosis. We aimed at identifying novel disease genes responsible for CMT2.
Silvia Cipriani   +23 more
wiley   +1 more source

Nanomaterial‐Integrated 3D Biofabricated Structures for Advanced Biomedical Applications

open access: yesMacromolecular Materials and Engineering, EarlyView.
This review investigates the integration of nanomaterials into 3D biofabricated structures, highlighting the potential in tissue regeneration, wound healing, and cancer therapy. It discusses key techniques, including bioprinting and electrospinning, while addressing challenges such as biocompatibility, scalability, and regulatory barriers.
Mustafijur Rahman   +9 more
wiley   +1 more source

Observations on the effects of the folic acid antagonists, aminopterin and amethopterin, in patients with advanced neoplasms [PDF]

open access: bronze, 1952
Emanuel B. Schoenbach   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy